Proteomic approaches in understanding a detected relationship between chemotherapy-induced nephrotoxicity and cell

Juliana Dinéia Perez1, Juliana Almada Colucci, Maísa Mayumi Sakata

  • 1Nephrology Division, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.

Nephron. Physiology
|June 11, 2011
PubMed
Abstract

Insights

Proteomics reveals distinct protein changes in kidney cells exposed to cisplatin and carboplatin, offering insights into chemotherapy-induced nephrotoxicity and potential biomarkers for safer cancer drugs.

Area of Science:

  • Proteomics
  • Chemotherapy
  • Nephrotoxicity

Background:

  • Chemotherapeutic agents often cause nephrotoxicity.
  • Proteomics is key to identifying protein responses to xenobiotics.

Purpose of the Study:

  • To investigate the proteomic changes in human renal proximal tubule epithelial cells (HK-2) exposed to cisplatin (CPT) and carboplatin (CB).
  • To understand the molecular mechanisms of CPT- and CB-induced nephrotoxicity.

Main Methods:

  • Two-dimensional gel electrophoresis (2-DE).
  • Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) analysis.
  • Tandem mass spectrometry.

Main Results:

  • CPT exposure led to the expression of ATP synthase subunit α and serine hydroxymethyltransferase, potentially as a protective response to cellular respiration damage.
  • Thioredoxin-dependent peroxide reductase was downregulated by CPT and upregulated by CB, suggesting different apoptotic pathway activations.
  • Identified differentially expressed proteins provide insights into metal-based drug nephrotoxicity mechanisms.

Conclusions:

  • The study offers insights into potential biomarkers for chemotherapy-induced nephrotoxicity.
  • Findings may aid in designing safer and more effective anticancer drugs with reduced side effects.

Related Concept Videos